HDSA Research Webinar: New Treatment for Chorea Associated with HD: On Friday, December 8 at 12:00 PM Eastern, join HDSA for a research webinar in which Neurocrine Biosciences, Inc. will discuss their new medication recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of chorea associated with HD in adults.
Speakers include Grace Liang, Vice President of Clinical Development, Neurocrine Biosciences, Jaeson Kaplan, Executive Director of Market Access, Neurocrine Biosciences, and Erin Furr Stimming, M.D., FAAN, FANA, Principal Investigator, Huntington Study Group and Professor of Neurology, McGovern Medical School, UTHealth Houston.
